1.
Jung S-H, Lee S-E, Lee M, Kim S-H, Yim S-H, Kim TW, Min C-K, Chung Y-J. Circulating microRNA expressions can predict the outcome of lenalidomide plus low-dose dexamethasone treatment in patients with refractory/relapsed multiple myeloma. Haematologica [Internet]. 2017Oct.27 [cited 2026Nov.10];102(11):e456-e459. Available from: https://haematologica.org/article/view/8267